Ocon Healthcare
Modi'in
About Ocon Healthcare
OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions. In addition to our flagship product, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $29.5M
- Funding stage: Early Stage Venture
- Last round: Grant (Jun 2024)
- Website: oconmed.com
- Phone: +972 72 21 50 105
Industries & Categories
Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/ocon-healthcare-117473 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.